Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry

Rahman, P; Zummer, M; Bessette, L; Baer, P; Haraoui, B; Chow, A; Kelsall, J; Kapur, S; Rampakakis, E; Psaradellis, E; Lehman, AJ; Nante, F; Osborne, B; Tkaczykl, C

Rahman, P (reprint author), Mem Univ Newfoundland, Med, St John, NF, Canada.

BMJ OPEN, 2017; 7 (8):

Abstract

Objective To describe the minimal disease activity (MDA) rate over time in patients with psoriatic arthritis (PsA) receiving antitumour necrosis facto......

Full Text Link